Cadre Holdings, Inc.

Análisis de la acción Cadre Holdings, Inc. (CDRE)

$27.070

+0.709 (+2.62%)Al cierre

Loading chart…
Máximo
27.080
Apertura
26.320
Precio medio ponderado por volumen
26.70
Volumen
520.03K
Capitalización
1.34B
Mínimo
25.945
Importe
13.88M
EV/EBITDA, TTM
11.84

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others.

Análisis de IA of Cadre Holdings, Inc. (CDRE)

Comprar

Cadre Holdings Inc is a good buy right now due to its recent positive performance and strong analyst ratings. The stock has seen a 7.45% increase over the last five days, and analysts have set a price target of $43, suggesting a potential upside of 63.1%. Additionally, the forward P/E ratio of 18.15 indicates that the stock may be undervalued compared to its growth prospects. However, the main risk is the recent insider selling by CEO Warren B. Kanders, who sold 75,000 shares, which could signal a lack of confidence in the company's near-term performance.

Métricas de valoración

El PER previsto actual de Cadre Holdings, Inc. (CDRE) es 18.15, frente a su media de 5 años de 30.25.

PER previsto

Valor razonable
Media 5A P/E
30.25
P/E actual
18.15
Sobrevalorada
46.24
Infravalorada
14.26

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
13.22
EV/EBITDA actual
11.84
Sobrevalorada
15.05
Infravalorada
11.39

Precio/ventas previsto

Infravalorado
Media 5A P/S
2.01
P/S actual
1.40
Sobrevalorada
2.34
Infravalorada
1.68

Escenarios de precio de Alphio AI para CDRE

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%CDRE

$34.59

Precio del escenario

B

Base

Base · 50%CDRE

$30.16

Precio del escenario

B

Bajista

Bajista · 25%CDRE

$29.75

Precio del escenario

Ballenas con CDRE en cartera

G

Greenhouse Funds LLLP

+ Con en carteraCDRE

+1.78%

Rentabilidad a 3 meses

Cronología de eventos

2026-08-05 (ET)

16:30:00

Company Reports Q2 Revenue of $207.1M, Exceeding Expectations

16:30:00

Cadre Raises 2026 Sales Guidance to $749-$769 Million

2026-06-02 (ET)

16:20:00

Cadre Holdings Subsidiary Safariland Wins $61 Million FBI Contract

2026-05-11 (ET)

16:30:00

Cadre Reports Q1 Revenue of $155.4M, Exceeds Expectations

16:30:00

Company Confirms FY26 Adjusted EBITDA View of $136M-$141M

Noticias

Preguntas frecuentes sobre CDRE, respondidas por Alphio AI

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others. It operates in the Industrials sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Cadre Holdings Inc is a good buy right now due to its recent positive performance and strong analyst ratings. The stock has seen a 7.45% increase over the last five days, and analysts have set a price target of $43, suggesting a potential upside of 63.1%. Additionally, the forward P/E ratio of 18.15 indicates that the stock may be undervalued compared to its growth prospects. However, the main risk is the recent insider selling by CEO Warren B. Kanders, who sold 75,000 shares, which could signal a lack of confidence in the company's near-term performance.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar